Search

Ionis Pharmaceuticals Inc

Uždarymo kaina

SektoriusSveikatos priežiūra

56.73 -2.69

Apžvalga

Akcijų kainos pasikeitimas

24 val.

Dabar

Min

56.08

Max

58.3

Pagrindiniai rodikliai

By Trading Economics

Pajamos

136M

-93M

Pardavimai

43M

246M

Pelnas, tenkantis vienai akcijai

-0.3

Pelno marža

-37.599

Darbuotojai

1,402

EBITDA

-4.7B

-69M

Rekomendacijos

By TipRanks

Rekomendacijos

Stiprus pirkimas

12 mėnesių prognozė

+61.56% upside

Dividendai

By Acuity

Kitas uždarbis

2026-07-29

Rinkos statistika

By TradingEconomics

Rinkos kapitalizacija

1.8B

14B

Ankstesnė atidarymo kaina

59.42

Ankstesnė uždarymo kaina

56.73

Naujienos nuotaikos

By Acuity

50%

50%

176 / 342 reitingas Healthcare

Ionis Pharmaceuticals Inc Grafikas

Ankstesni rezultatai nėra patikimas būsimų rezultatų rodiklis.

Susijusios naujienos

2026-07-13 23:41; UTC

Correlated Moves
News
Macro News
ETF Constituents

Vanguard Information Technology ETF declined in after-market hours amid rising crude oil prices and negative sentiment from Oracle's losses, impacting major tech stocks.

2026-07-13 23:26; UTC

News

Shares of Netflix are higher in after-market hours as options traders make bullish bets ahead of the earnings report on July 16.

2026-07-13 23:16; UTC

News

Marriott International will release second-quarter 2026 earnings on August 3, 2026. Shares are higher in after-hours trading, though near the lower end of their range.

2026-07-13 23:11; UTC

News

USD/THB is advancing in Monday's session, supported by a recovery from earlier lows. Rising inflation concerns are influencing market dynamics ahead of upcoming reports.

2026-07-13 23:06; UTC

Social Media
News

Biogen received FDA approval for LEQEMBI IQLIK, a subcutaneous Alzheimer's treatment, boosting shares modestly higher in after-market trading.

2026-07-13 22:51; UTC

News

Vanguard Mortgage-Backed Securities ETF is trading lower in after-market hours, influenced by rising crude oil prices and concerns over inflation and interest rates.

2026-07-13 22:51; UTC

News

The USD/ZAR is trading higher amid geopolitical tensions following U.S. strikes against Iran, maintaining strength near its one-month range.

2026-07-13 22:31; UTC

News
ETF Constituents

Vanguard Growth ETF trades higher in after-market hours, supported by Nvidia and Texas Instruments, amid rising crude oil prices and inflation concerns.

2026-07-13 22:31; UTC

News
Correlated Moves

iShares 7-10 Year Treasury Bond ETF rises slightly after market close, amid rising crude oil prices and inflation concerns influencing broader market volatility.

2026-07-13 22:21; UTC

News

Vanguard Total Bond Market ETF is modestly higher in after-market trading as crude oil prices rise amid escalating U.S.-Iran military tensions.

2026-07-13 22:01; UTC

News

The USD/HUF is gaining, reaching a session high as rising oil prices heighten inflation concerns and potential Federal Reserve interest rate hikes.

2026-07-13 21:51; UTC

Correlated Moves
News

The iShares 20+ Year Treasury Bond ETF is slightly higher in after-market trading as rising U.S. Treasury yields follow President Trump's Iranian blockade announcement.

2026-07-13 20:21; UTC

Correlated Moves
News
ETF Constituents

The Russell 2000 Index is modestly lower after-market, reflecting broader market declines amid U.S.-Iran tensions. Vanguard Small-Cap ETF remains little changed.

2026-07-13 20:07; UTC

Social Media
News

American Airlines Group shares are lower amid concerns over high debt and disappointing revenue passenger miles, despite some optimistic social media discussions.

2026-07-13 20:07; UTC

News
Correlated Moves

Ethereum is trading lower as geopolitical tensions raise inflation concerns and increase market volatility. The cryptocurrency fell from an earlier session high.

2026-07-13 20:07; UTC

Correlated Moves
News

Ethereum is trading lower as geopolitical tensions raise inflation concerns and increase market volatility. The asset remains above its 20-day moving average.

2026-07-13 20:07; UTC

News
Correlated Moves
Social Media

The Polish zloty has weakened, contributing to a modest rise in USD/PLN since Friday's close amid increased military tensions and inflation concerns.

2026-07-13 20:07; UTC

News
Correlated Moves

Silver/NZD declines amid rising inflation concerns linked to surging crude oil prices and fears of interest rate hikes. The asset has closed lower for three sessions.

2026-07-13 20:07; UTC

Correlated Moves
News

Silver is declining amid rising inflation concerns linked to crude oil prices and U.S.-Iran tensions. The asset has pulled back from earlier session gains.

2026-07-13 20:07; UTC

News
Correlated Moves

Silver Ounce vs Euro is declining amid rising inflation concerns linked to crude oil prices and U.S.-Iran tensions, marking three consecutive sessions lower.

2026-07-13 20:07; UTC

Correlated Moves
News

Silver declines amid rising inflation concerns and crude oil price surge. The asset has pulled back from earlier gains, continuing a downward trend.

2026-07-13 20:07; UTC

News
Correlated Moves

Silver declines amid rising inflation concerns linked to crude oil prices. The asset has pulled back from earlier gains and remains below its 20-day moving average.

2026-07-13 20:07; UTC

News
Correlated Moves

USD/CZK is trading higher, supported by broader gains and approaching the upper end of its one-month range amid inflation data and Federal Reserve policy focus.

2026-07-13 20:07; UTC

News
Correlated Moves

The US Dollar Index's rise supports USD/DKK, which is higher since Friday's close. Concerns over U.S.-Iran military actions impact market sentiment.

2026-07-13 20:06; UTC

News

Fiserv shares are higher as leadership changes prompt analysts to monitor potential impacts. The company is also considering the sale of its STAR payment network.

2026-07-13 20:06; UTC

News
Social Media

MercadoLibre opens a new distribution center in Nuevo León, Mexico, creating over 2,000 jobs and enhancing logistics amid rising e-commerce demand. Shares are higher.

2026-07-13 20:06; UTC

News

Gold is trading higher, supported by inflation concerns linked to rising crude oil prices amid U.S.-Iran tensions. Silver has declined after earlier gains.

2026-07-13 20:06; UTC

Correlated Moves
News

The USD/SGD is trading higher, reflecting strength near its one-month range. Broader market dynamics and geopolitical tensions are influencing currency movements.

2026-07-13 20:06; UTC

Correlated Moves
News

The USD/SEK is trading higher, influenced by broader currency market movements and concerns over supply disruptions in the Strait of Hormuz.

2026-07-13 20:06; UTC

News
Correlated Moves

Silver/JPY is declining amid rising inflation concerns linked to crude oil prices and escalating U.S.-Iran tensions. The asset has traded lower for three consecutive sessions.

Akcijų palyginimas

Kainos pokytis

Ionis Pharmaceuticals Inc Prognozė

Kainos tikslas

By TipRanks

61.56% į viršų

12 mėnesių prognozė

Vidutinis 94.11 USD  61.56%

Aukščiausias 125 USD

Žemiausias 68 USD

Remiantis 19 „Wall Street“ analitikais, siūlančiais 12 mėnesių tikslines Ionis Pharmaceuticals Inc kainas – Dist per pastaruosius 3 mėnesius.

Bendras įvertinimas

By TipRanks

Stiprus pirkimas

19 ratings

17

Pirkti

2

Laikyti

0

Parduoti

Rinkos nuotaikos

By Acuity

176 / 342 reitingas Sveikatos priežiūra

Naujienos nuotaikos

Neutral

Svyravimai

Žemiau vidurkio

Naujienų apimtis (RCV)

Žemiau vidurkio

Finansinės naujienos

Pardavimo ir administravimo išlaidos

Veiklos sąnaudos

Ikimokestinis pelnas

Pardavimai

Pardavimo savikaina

Bendrasis pelnas iš pardavimo

Skolų palūkanų išlaidos

EBITDA

Veiklos pelnas

$

Apie bendrovę Ionis Pharmaceuticals Inc

Ionis Pharmaceuticals, Inc. discovers and develops RNA-targeted therapeutics in the United States. The company offers SPINRAZA for spinal muscular atrophy (SMA) in pediatric and adult patients; TEGSEDI, an antisense injection for the treatment of polyneuropathy caused by hereditary transthyretin amyloidosis in adults; and WAYLIVRA, an antisense medicine for treatment for familial chylomicronemia syndrome (FCS) and familial partial lipodystrophy. It also develops medicines for various indications that are in phase 3 study, including Eplontersen as a monthly self-administered subcutaneous injection to treat all types of ATTR; Olezarsen for patients with FCS and severe hypertriglyceridemia (SHTG); Donidalorsen for patients with hereditary angioedema; ION363 for patients with amyotrophic lateral sclerosis; Tofersen to inhibit the production of superoxide dismutase 1; Pelacarsen for patients with established cardiovascular disease and elevated lipoprotein(a); and Bepirovirsen to inhibit the production of viral proteins associated with hepatitis B virus. In addition, the company develops IONIS-FB-LRx to inhibit the production of complement factor B and the alternative complement pathway; and ION224 to reduce the production of diacylglycerol acyltransferase 2. It has a strategic collaboration with Biogen for the treatment of neurological disorders; and collaboration and license agreement with Metagenomi, Inc, AstraZeneca, Bayer AG, GlaxoSmithKline plc, Novartis, Roche, Swedish Orphan Biovitrum AB, and PTC Therapeutics. The company was incorporated in 1989 and is based in Carlsbad, California.
help-icon Live chat